The FDA is currently operating under a partial shutdown due to the U.S. government's October 1, 2025, lapse in appropriations. While mission-critical public health and safety activities will continue, such as food and drug safety monitoring and emergency response, the agency has halted the acceptance of any new submissions that require user fees. Other impacts include delays in routine inspections and non-urgent communications, with most non-essential staff furloughed.